NasdaqGM:VCELBiotechs
Vericel (VCEL) Could Be 33% Undervalued After Insider Sales Raised Fresh Questions
Vericel (VCEL) is in focus after several senior executives exercised stock options and sold shares in late June under pre-arranged Rule 10b5-1 trading plans, drawing attention to insider activity at the company.
See our latest analysis for Vericel.
Against this insider activity backdrop, Vericel’s share price has climbed to $46.98, with a 1-day share price return of 4.05% and a 30-day share price return of 31.63%. The 1-year total shareholder return of 12.55% and 5-year total shareholder...